Paragraph 1 I1

United Kingdom

In Annex II to the EEA agreement, in Part 2—

F1(a)

omit point 12n (including the words from “The provisions of the Regulation” to the end);

(b)

omit point 12o (including the words from “The provisions of the Regulation” to the end);

(c)

in point 12zze—

(i)

omit “32017 R 0542: Commission Regulation (EU) 2017/542 of 22 March 2017 (OJ L.78, 23.3.2017, p.1)”;

F2(ii)

omit “32020 R 0011: Commission Delegated Regulation (EU) 2020/11 of 29 October 2019 (OJ L 6, 10.1.2020, p. 8)”;

F3(iii)

after “The Provisions of Regulation (EC) No 1272/2008 shall, for the purpose of this Agreement, be read with the following adaptations:” omit points (a) and (b);

(d)

omit point 12zzf.

Annotations

Textual amendments

F1: Sch. 3 para. 1(a)(b) substituted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 3 para. 1(a)
F2: Sch. 3 para. 1(c)(ii) inserted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 3 para. 1(b)(ii)
F3: Sch. 3 para. 1(c)(ii) renumbered as Sch. 3 para. 1(c)(iii) (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 3 para. 1(b)(i)

Commencement

I1: Sch. 3 para. 1 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)